ArticleJournal of managed care & specialty pharmacy2026
Pathways for innovation-Expansion of health system specialty pharmacy services: A pilot initiative in dermatology and rheumatology clinics.
Article in Journal of managed care & specialty pharmacy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hospitals incorporate health system specialty pharmacies (HSSPs) to drive efficient, collaborative care and improve health outcomes for patients with complex, resource-intensive conditions. Specialty pharmacy teams, made up of clinical pharmacists, pharmacy technicians, and ancillary staff, provide vertically integrated, comprehensive, and coordinated care. Benefits of HSSPs to patients and health systems include improved utilization of medications (ie, access, initiation, and adherence) and enhanced health care services. Strategies for expanding the footprint of specialty services have not been well described. The purpose of this report is to share a model of HSSP clinical services and a framework for service expansion that ensures sustainable and equitable care across the health system. UC Davis Health established an internal HSSP to deliver comprehensive clinical services to 12 specialty therapeutic areas. Further service expansion was vital to ensure comprehensive and equitable services were provided to all patients. Service location was identified as a primary source of the disparities in care between hospital- and community-based clinics. Remedying these disparities required recognition of service gaps and barriers, strategic planning, stakeholder engagement, and workflow modification. Standardized therapy-specific outcomes (TSOs) were developed in collaboration with pharmacists and physician champions. Legal counsel and 340B Health resources guided compliance with regulatory standards. Information technology facilitated the implementation of the new operational workflow. Outcomes of the initiative included referral and enrollment rates, time to treatment, patient cost savings, medication adherence, and provider satisfaction. This report describes a model for expansion of an HSSP framework that supports growth of comprehensive and equitable pharmacy services, meaningful metrics and tracking, and patient outcomes. Beneficial outcomes included time to treatment, patient cost savings, medication adherence, TSO tracking, and provider satisfaction.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.